Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | HR+ | Luminal | CGC-11047 | Polyamine analogue | 1.6 | uM | 7875.018 | 0.8343 | 0.7928 | 1.6565 | ||
MCF7 | HR+ | Luminal | CGC-11047 | Polyamine analogue | 5000 | uM | 7874.018 | 0.0776 | -0.5749 | 1.6506 | ||
MCF7 | HR+ | Luminal | CGC-11047 | Polyamine analogue | 200 | uM | 7874.018 | 0.7299 | 0.6527 | 1.6506 | ||
MCF7 | HR+ | Luminal | CGC-11047 | Polyamine analogue | 1000 | uM | 7874.018 | 0.6482 | 0.5380 | 1.6506 | ||
MCF7 | HR+ | Luminal | CGC-11047 | Polyamine analogue | 0.32 | uM | 7875.018 | 0.9399 | 0.9265 | 1.6565 | ||
MCF7 | HR+ | Luminal | CGC-11047 | Polyamine analogue | 0.0128 | uM | 7875.018 | 0.9910 | 0.9891 | 1.6565 | ||
MCF7 | HR+ | Luminal | CGC-11047 | Polyamine analogue | 0.064 | uM | 7875.018 | 0.9735 | 0.9679 | 1.6565 |